Joyce C, Freund M, Peterson R N
Contraception. 1979 Jan;19(1):95-106. doi: 10.1016/s0010-7824(79)80012-8.
Eight single-drug and combinations of two-drug treatments were used to study the contraceptive efficacy of the intravaginal application of acrosin inhibitors (TLCK; NPGB) and hyaluronidase inhibitors (Compound 53D/k; Phosphorylated hesperidin) in the rabbit. Drug concentrations were selected so that they did not inhibit rabbit sperm motility upon incubation at 37 degrees C for 30 minutes. In the first series, the drugs were added to semen before artificial insemination; in the second series, the drugs were administered intravaginally before artificial insemination with untreated rabbit semen. The data show that these drugs are highly effective intravaginal contraceptives in the rabbit. The data suggest that this is a specific inhibitory effect on fertilization since the drug concentrations used did not affect sperm motility.
使用八种单药及两种药物组合治疗方法,研究了在兔体内经阴道应用顶体酶抑制剂(甲苯磺酰-L-赖氨酸氯甲基酮;N-对甲苯磺酰苯甲酰-L-精氨酸乙酯盐酸盐)和透明质酸酶抑制剂(化合物53D/k;磷酸化橙皮苷)的避孕效果。选择药物浓度,使其在37℃孵育30分钟后不会抑制兔精子活力。在第一组实验中,将药物在人工授精前添加到精液中;在第二组实验中,在使用未处理的兔精液进行人工授精前经阴道给药。数据表明,这些药物在兔体内是高效的经阴道避孕药。数据表明这是对受精的特异性抑制作用,因为所用药物浓度不影响精子活力。